Rebif New Formulation (RNF) in Relapsing Forms of Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Pfizer
Related studies linked through entity extraction aliases.
Linezolid in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections
- Status
- TERMINATED
- Phase
- PHASE3
A 6-Month Study Of CP-690,550 Versus Tacrolimus In Kidney Transplant Patients
- Status
- COMPLETED
- Phase
- PHASE2
Study Evaluating Biomarkers In Relapsed/Refractory Pediatric Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Neoadjuvant Colorectal Cancer With Unresectable Liver Metastases
- Status
- TERMINATED
- Phase
- PHASE2
Sildenafil for Chronic Obstructive Pulmonary Disease
- Status
- COMPLETED
- Phase
- PHASE2
A Research Study of CP-724,714 in Patients With HER2 Overexpressing Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine.
- Status
- COMPLETED
- Phase
- PHASE3
Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of Antiretroviral-Experienced NonCCR5-Tropic HIV-1 Infected Subjects
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Trial of Maraviroc (UK-427,857) in Combination With Zidovudine/Lamivudine Versus Efavirenz in Combination With Zidovudine/Lamivudine
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE3
Safety Study of an Immune Response Modifier in Patients With Refractory Solid Organ Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of the Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor (GIST) Who May Derive Benefit From Treatment With SU011248
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Study Of SU011248 In Patients With Metastatic Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of an Immune Response Modifier to Treat Inoperable Advanced Melanoma Skin Lesions
- Status
- COMPLETED
- Phase
- PHASE1